Unlock instant, AI-driven research and patent intelligence for your innovation.

Arformoterol tartrate aerosol and preparation method thereof

A tartaric acid and aerosol technology, applied in the field of biomedicine, can solve the problems of complex preparation process, unfavorable portability, high price, etc., and achieve the effect of simple preparation process, preparation uniformity and high quality standard

Inactive Publication Date: 2020-02-07
南京华盖制药有限公司
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compared with the three, the inhalation preparation has the best effect, but it needs to be matched with a specific nebulizer, which is expensive and not easy to carry. On the one hand, the powder aerosol also needs a supporting nebulizer device, and on the other hand, its bioavailability is low And the preparation process is complex (multi-step pulverization machine tools are required, which may easily cause dust pollution in the factory area)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Arformoterol tartrate aerosol and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Weigh 0.45g of arformoterol tartrate, add it into a 20L predissolved tank containing 18L water for injection, use a heating mantle outside the predissolved tank (hot water can be passed through, cold water can control the temperature in the tank), stir at 15°C to completely dissolve and clarify, and weigh again Add 9g of thiourea into the pre-dissolving tank, and stir at 15°C to dissolve completely. Weigh 30g of ethanol and add it to the above solution, continue to stir at this temperature for 5 minutes, transfer the above-prepared arformoterol tartrate aqueous solution to a 100L liquid mixing tank, add water for injection at about 15°C, and make the total solution reach 48L. Add 455g of sodium chloride, the test osmotic pressure is 276mOsmol / kg, and use acetic acid-sodium acetate buffer solution to adjust the pH value of the solution in the mixing tank to 5.0, continue stirring in the mixing tank and when the temperature is maintained at 15°C, add 15°C The volume of wa...

Embodiment 2

[0047] Weigh 0.474g of arformoterol tartrate, add it into a 30L predissolved barrel containing 24L water for injection, use a heating mantle outside the predissolved barrel (hot water can be passed through, cold water can control the temperature in the canister), stir at 25°C to completely dissolve and clarify, and weigh again Add 24g of glycine into the pre-dissolving tank, and stir at 25°C to dissolve completely. Weigh 150g of ethanol and add it to the above solution, continue to stir at this temperature for 7 minutes, transfer the above-prepared arformoterol tartrate aqueous solution to a 100L liquid mixing tank, add water for injection at about 25°C, and make the total solution reach 51L. Add 2680g of glucose, test the osmotic pressure to be 282mOsmol / kg, and use citric acid-sodium citrate buffer solution to adjust the pH value of the solution in the mixing tank to 5.5, continue stirring in the mixing tank and keep the temperature at 25°C, add Set the volume to 60L with wa...

Embodiment 3

[0049] Weigh 0.465g of arformoterol tartrate, add it into a 30L predissolved tank containing 20L water for injection, use a heating mantle outside the predissolved tank (hot water can be passed through, cold water can control the temperature in the tank), stir at 20°C to completely dissolve and clarify, and weigh again Add 20g of nicotinamide into the pre-dissolve tank, and stir at 20°C to dissolve completely. Weigh 100g of propylene glycol and add it to the above solution, continue to stir at this temperature for 6 minutes, transfer the above-prepared arformoterol tartrate aqueous solution to a 100L liquid mixing tank, add water for injection at about 20°C, and make the total solution reach 50L. Add 448g of sodium chloride, the test osmotic pressure is 288mOsmol / kg, and use phosphoric acid-sodium phosphate buffer solution to adjust the pH value of the solution in the liquid mixing tank to 5.2, continue stirring in the liquid mixing tank and when the temperature is maintained a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biological medicines, and particularly relates to arformoterol tartrate aerosol and a preparation method thereof, the arformoterol tartrate aerosol takes arformoterol tartrate as an active ingredient, and also comprises a stabilizer, a latent solvent, a propellant, an osmotic pressure regulator, a pH value regulator and water for injection as a solvent. The arformoterol tartrate aerosol provided by the invention is simple in preparation process, low in cost, high in liquid medicine stability, high in quality standard and suitable for being used by vast patients.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to an arformoterol tartrate aerosol and a preparation method thereof. Background technique [0002] Arformoterol tartrate, generic name: Arformoterol Tartrate, molecular formula: C 19 h 24 N 2 o 4 ·C 4 h 6 o 6 , molecular weight: 494.5, its structural formula is: [0003] [0004] Arformoterol tartrate inhalation preparation was developed and launched by SUNOVION in 2006, trade name: BROVANA @ , clinically mainly used for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. WHO reports that about 300 million people worldwide suffer from asthma, and about 250,000 people die from the disease every year. The disease can occur in all age groups. In recent years, the prevalence of children has been on the rise globally. Asthma is a disease with a high incidence among respira...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K9/12A61K47/20A61K47/18A61K47/22A61K47/12A61K47/10A61K31/167A61P11/00
CPCA61K9/0073A61K31/167A61K47/10A61K47/12A61K47/183A61K47/20A61K47/22A61P11/00
Inventor 孙向阳朱景阳娄媛媛
Owner 南京华盖制药有限公司